The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Antimicrobial Resistance Surveillance Market By 2030 Starting From Its 2026 Size?
The antimicrobial resistance surveillance market has demonstrated robust growth in recent years. This market is expected to expand from $7.3 billion in 2025 to $7.91 billion in 2026, registering a compound annual growth rate (CAGR) of 8.4%. The factors contributing to its historical growth include an increase in drug-resistant infections, various hospital infection control initiatives, extensive public health surveillance programs, the expansion of laboratory testing, and ongoing concerns about antibiotic misuse.
The antimicrobial resistance surveillance market is projected to experience robust expansion over the coming years. It is anticipated to reach $10.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This projected growth during the forecast period can be attributed to factors such as global antimicrobial resistance (AMR) monitoring initiatives, predictive surveillance powered by AI, cloud-based mechanisms for data sharing, the expansion of genomic surveillance, and reporting mandates driven by policy. Key trends expected during the forecast period encompass real-time tracking of resistance patterns, surveillance utilizing whole genome sequencing, AI-driven resistance analytics, integrated databases for public health, and AMR tracking systems implemented across hospitals.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
What Primary Drivers Are Shaping The Development Of The Antimicrobial Resistance Surveillance Market?
The increasing prevalence of infectious diseases is poised to fuel the expansion of the antimicrobial resistance surveillance market moving forward. Infectious diseases are conditions caused by harmful microbes such as bacteria, viruses, fungi, or parasites that have the ability to spread from one person to another, either directly or indirectly. This escalating occurrence of infectious diseases is attributed to factors like climate change, increased urbanization, and global travel, all of which contribute to enhanced pathogen dissemination and greater human exposure to new microbes. Antimicrobial resistance surveillance is instrumental in tracking the spread of resistant pathogens, thereby guiding effective treatment strategies and informing public health initiatives to combat infectious diseases. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the rising prevalence of infectious diseases is a key factor propelling the growth of the antimicrobial resistance surveillance market.
Which Segment Categories Define The Antimicrobial Resistance Surveillance Market?
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
What Major Market Trends Are Driving Changes In The Antimicrobial Resistance Surveillance Market?
Leading companies in the market are concentrating on innovative technologies, such as advanced diagnostic instruments, to streamline operations, enhance effectiveness, improve precision, reduce costs, and deliver superior results for patients and end-users. A diagnostic tool is defined as any device, apparatus, software, or method utilized to pinpoint, identify, or evaluate the presence of a condition, ailment, malfunction, or issue. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based producer and supplier of diagnostic product services, announced the introduction of the PA-100 AST Point-of-Care Testing System. This system enables the rapid and accurate detection of antimicrobial resistance directly at the point of care, providing a notable reduction in time compared to traditional laboratory methods, which can often take up to several days. By delivering results in just 30 minutes, it allows clinicians to make prompt and informed decisions regarding suitable infection treatments, decreasing reliance on broad-spectrum antibiotics and aiding in the fight against the spread of antimicrobial resistance.
Who Are The Top Companies Competing In The Antimicrobial Resistance Surveillance Market?
Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.
Read the full antimicrobial resistance surveillance market report here:
How Does The Antimicrobial Resistance Surveillance Market Perform Across Major Global Regions?
North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antimicrobial Resistance Surveillance Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Resistance Surveillance Market 2026, By The Business Research Company
Pediatric Orthopedic Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/pediatric-orthopedic-implants-global-market-report
Orthopedic Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report
Orthopedic Regenerative Surgical Products Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model